The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease
Open accessAbstract
Sickle cell disease (SCD) is associated with early mortality. We sought to determine the incidence, cause, and risk factors for death in an adult population of patients with SCD. All patients aged ≥18 years seen at the Adult Sickle Cell Center at Duke University Medical Center between January 2000 and April 2005 were enrolled. Forty‐three patients (21 males and 22 females) died during the study period. The median age of survival was 39 years for females (95% CI: 34–56), 40 years for males (95% CI: 34–48), and 40 years overall (95% CI: 35–48). Cardiac causes of death accounted for 25.6% (11/43 patients); pulmonary, 14.0% (six patients); other SCD related, 32.6% (14 patients); unknown, 14.0% (six patients); and others, 14.0% (six patients). Pulseless electrical activity arrest, pulmonary emboli, multiorgan failure, and stroke were the most frequent causes of death. Among the deceased patients, the most common premorbid conditions were cardiopulmonary: acute chest syndrome/pneumonia (58.1%), Pulmonary hypertension (pHTN; 41.9%), systemic HTN (25.6%), congestive heart failure (25.6%), myocardial infarction (20.9%), and arrhythmias (14.0%). Tricuspid regurgitant jet velocity was significantly higher (3.1 m/sec vs. 2.6 m/sec, P < 0.001) and hemoglobin significantly lower (8.3 g/dL vs. 9.2 g/dL, P < 0.05) in deceased patients when compared with patients who lived, respectively. With improved preventive and therapeutic advances, including hydroxyurea therapy, acute complications such as infection are no longer the leading cause of death; instead, causes of death and premorbid conditions are shifting to chronic cardiopulmonary complications. Further, arrhythmia leading to premature death is under‐recognized in SCD and warrants further investigation. Am. J. Hematol., 2010. © 2009 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552
Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320 · cited 2×
“In 1994, prior to the widespread use of hydroxyurea, Platt et al studied patients with SCD who ranged from birth to 66 years of age(9).”
BackgroundEffect of hydroxyurea on the frequency of painful crises in sickle cell anemia
Charache, S., Terrin, M. L., Moore, R. D., Dover, G. J., Barton, F. B., Eckert, S. V., McMahon, R. P., & Bonds, D. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322001 · Cited by 2,340
Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035477 · Cited by 1,325
Pulmonary hypertension in patients with sickle cell disease: a longitudinal study
Ataga, K. I., Moore, C. G., Jones, S., Olajide, O., Strayhorn, D., Hinderliter, A., & Orringer, E. P. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06110.x · Cited by 298
N-Terminal Pro-Brain Natriuretic Peptide Levels and Risk of Death in Sickle Cell Disease
Machado, R. F., Anthi, A., Steinberg, M. H., Bonds, D., Sachdev, V., Kato, G. J., Taveira-DaSilva, A. M., Ballas, S. K., Blackwelder, W., Xu, X., et al. (2006) · JAMA · doi:10.1001/jama.296.3.310 · Cited by 197
Research works printed but not linked: 42
- Diggs LM, 1973, Sickle Cell Disease: Diagnosis, Management, Education and Research, 189
- 10.1002/ajh.10427 · DOI
- 10.1182/blood-2002-03-0948 · DOI · Paper page
- 10.1542/peds.84.3.500 · DOI · Paper page
- 10.1097/01.md.0000189089.45003.52 · DOI · Paper page
- 10.2105/AJPH.87.8.1317 · DOI
- From the Centers for Disease Control and Prevention, 1998, Mortality among children with sickle cell disease identified by newborn screening during 1990–1994: California, Illinois, and New York, JAMA, 279, 1059, 10.1001/jama.279.14.1059 · DOI
- 10.1182/blood-2003-11-3758 · DOI · Paper page
- 10.1001/jama.289.13.1645 · DOI · Paper page
- 10.1111/j.1365-2141.2007.06822.x · DOI
- 10.1002/ajh.21058 · DOI · Paper page
- 10.1002/ajh.21039 · doi:10.1002/ajh.21039
- 10.1002/ajh.21083 · DOI
- 10.3324/haematol.11213 · DOI
- 10.1016/j.jacc.2006.09.038 · DOI · Paper page
- 10.1002/ajh.21016 · DOI
- 10.1136/jcp.44.6.459 · DOI
- Tattah E, 1975, Death patterns in sickle cell anemia, JAMA, 233, 889, 10.1001/jama.1975.03260080051021 · doi:10.1001/jama.1975.03260080051021
- 10.1016/S0379-0738(02)00268-2 · DOI
- 10.1046/j.1365-2141.2003.04594.x · DOI · Paper page
- 10.1097/01.paf.0000257397.92466.50 · DOI
- 10.1136/bmj.285.6342.633 · DOI · Paper page
- 10.1097/00000441-200303000-00001 · DOI
- 10.1182/blood-2004-01-0322 · DOI
- 10.1002/(SICI)1099-0496(199909)28:3<205::AID-PPUL8>3.0.CO;2-Z · doi:10.1002/(sici)1099-0496(199909)28:3<205::aid-ppul8>3.0.co;2-z
- 10.1002/ajh.20485 · DOI
- 10.1002/clc.4960060707 · DOI
- 10.1056/NEJMoa013474 · DOI · Paper page
- 10.1016/S0002-9149(02)03177-6 · DOI
- 10.1001/jama.2008.598 · DOI
- Mansi IA, 2002, Myocardial infarction in sickle cell disease, J Natl Med Assoc, 94, 448
- 10.1007/s002470050759 · DOI
- 10.1016/S0002-9343(01)00835-X · DOI
- Raman SV, 2006, Myocardial ischemia and right ventricular dysfunction in adult patients with sickle cell disease, Haematologica, 91, 1329
- Norris S, 1991, Sickle cell anemia: Does myocardial ischemia occur during crisis?, J Natl Med Assoc, 83, 209
- 10.1182/blood-2007-04-084921 · DOI · Paper page
- 10.1182/blood.V96.1.76 · DOI · Paper page
- 10.1016/S0037-1963(01)90060-5 · DOI
- 10.1016/0002-9343(71)90240-3 · DOI · Paper page
- 10.1056/NEJM199409013310902 · DOI · Paper page
- 10.1002/ajh.20809 · DOI · Paper page
- 10.1016/S0037-1963(01)90058-7 · DOI
Cited by
Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61029-x · Cited by 2,504
Ware, R. E., de Montalembert, M., Tshilolo, L., & Abboud, M. R. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30193-9 · Cited by 977
Pathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
Factors associated with survival in a contemporary adult sickle cell disease cohort
Elmariah, H., Garrett, M. E., De Castro, L. M., Jonassaint, J. C., Ataga, K. I., Eckman, J. R., Ashley‐Koch, A. E., & Telen, M. J. (2014) · American Journal of Hematology · doi:10.1002/ajh.23683 · Cited by 300
Self-citationSickle cell disease related mortality in the United States (1999-2009)
Hamideh, D., & Alvarez, O. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24557 · Cited by 290
Metadata
- Authors
- Fitzhugh, C. D., Lauder, N., Jonassaint, J. C., Telen, M. J., Zhao, X., Wright, E. C., Gilliam, F. R., & De Castro, L. M.
- Venue
- American Journal of Hematology
- Publisher
- Wiley
- Published
- 2009-12-22
- Volume
- 85
- Issue
- 1
- Pages
- 36-40
- ISSN
- 0361-8609 (ISSN-L)
- 1096-8652
- OpenAlex
- W2004524066
- Cited by
- 224
- References
- 7
- FWCI
- 3.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.